Leadership

Academic Advisory Board

James O. Armitage, MD

Advisory Board Member

Dr. Armitage is globally recognized as a leading expert on non-Hodgkin lymphoma, and has played a critical role in advancing bone marrow transplantation. He developed and directed the bone marrow transplant programs at the University of Iowa and later at the University of Nebraska, where he also served as vice chair of Internal Medicine, chief of the Section of Oncology and Hematology, chair of the Department of Internal Medicine, and dean of the College of Medicine.

Marc Lippman, MD

Advisory Board Member

Marc E. Lippman, MD, MACP FRCP is a professor of Oncology and co-directs the breast cancer program at the Lombardi Comprehensive Cancer Center at Georgetown University. Prior to that he was the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard School of Medicine, and was Chairman of the Department of Medicine from May 2007 to May 2012 and Deputy Director of the Sylvester Comprehensive Cancer Center. Dr. Lippman completed his residency on the Osler Medical Service, John Hopkins University Hospital and completed a Fellowship in Endocrinology at Yale Medical School.

John Lister, MD

Advisory Board Member

John Lister, MD is currently the Chief of Hematology and Cellular Therapy at Allegheny Health Network. Dr. Lister received his Medical degree from Queens University in Kingston, Ontario; conducted post-graduate work at McGill University in Montreal with a fellowship in internal medicine and hematology; served as a Perry Fox Fellow at the Ontario Cancer Institute and Princess Margaret Hospital in Toronto. Dr. Lister was a member of the McGill University faculty at the Royal Victoria Teaching Hospital, and a faculty member at the University of Pittsburgh as a specialist in lymphoma and bone marrow transplantation before going to Allegheny Health Network, a subsidiary of Highmark Health.

John C. Ruckdeschel, MD

Advisory Board Member

Dr. Ruckdeschel is a leading authority on the diagnosis and management of thoracic malignancies with particular expertise in lung cancer. He received his BSc in biology from Rensselaer Polytechnic Institute and his MD from Albany Medical College in New York. He trained at Hopkins (Osler Intern), Beth Israel (Resident) and the National Cancer Institute (Fellow).

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from Oncology Analytics.

You have Successfully Subscribed!

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from Oncology Analytics.

You have Successfully Subscribed!